Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.

Last updated on 22-8-2019 by Anonymous (non vérifié)

Peer reviewed scientific article



The efficacy of two marker vaccines against classical swine fever (CSF) was tested in a large scale laboratory trial in several National Swine Fever Laboratories (NSFL) of the EU member states. The vaccines were: BAYOVAC CSF Marker (Vaccine A) from Bayer, Leverkusen, Germany and PORCILIS PESTI (Vaccine B) from Intervet, Boxmeer, The Netherlands. At the NSFL of Belgium, The Netherlands and Germany experiments were carried out to examine the ability of the vaccines to prevent transplacental transmission of CSF virus. In Belgium and The Netherlands pregnant sows were vaccinated once and challe…

Associated health topics:

QR code

QR code for this page URL